Audrey Rousseau

Summary

Country: France

Publications

  1. doi request reprint The 2007 WHO classification of tumors of the central nervous system - what has changed?
    Audrey Rousseau
    Neuropathology Department, Pitie Salpetriere Hospital, Paris, France
    Curr Opin Neurol 21:720-7. 2008
  2. doi request reprint Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade
    Audrey Rousseau
    UPMC INSERM U711 Neuro Oncologie expérimentale, Paris, France
    J Neurooncol 97:353-64. 2010
  3. doi request reprint Genomic changes in progression of low-grade gliomas
    Ahmed Idbaih
    INSERM Unité 711, Paris, France
    J Neurooncol 90:133-40. 2008
  4. pmc Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas
    Ahmed Idbaih
    Institut National de la Sante et de la Recherche Medicale, U711, Universite Pierre et Marie Curie, Hopital Pitie Salpetriere, Paris, France
    Neuro Oncol 10:540-7. 2008
  5. doi request reprint Complete response after one cycle of temozolomide in an elderly patient with glioblastoma and poor performance status
    François Ducray
    INSERM, Unité U711, Universite Pierre et Marie Curie Paris VI, Paris, France
    J Neurooncol 88:185-8. 2008
  6. doi request reprint A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry
    Soufiane El Hallani
    UMR975, Hopital de la Salpetriere, Universite Pierre et Marie Curie, Paris, France
    Brain 133:973-82. 2010
  7. doi request reprint Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma
    Mathieu Rodero
    Laboratoire d Immunologie Cellulaire, L Institut National de Santé et de Recherche Médicale U543, Paris, France
    J Clin Oncol 26:5957-64. 2008
  8. doi request reprint Intracranial solitary fibrous tumor: imaging findings
    Frédéric Clarençon
    Department of Neuroradiology, Pitie Salpetriere Hospital, APHP, 75013 Paris, France
    Eur J Radiol 80:387-94. 2011
  9. doi request reprint Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors
    Ahmed Idbaih
    INSERM, Unité 711, Paris, Universite Pierre et Marie Curie PARIS6, Laboratoire Biologie des Interactions Neurone Glie, Groupe Hospitalier Pitie Salpetriere, Paris, France
    Brain Res 1198:16-20. 2008
  10. doi request reprint PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors
    Franck Bielle
    APHP, Hopital Robert Debre, Service de Pathologie, Paris, France
    Am J Surg Pathol 36:1141-9. 2012

Collaborators

Detail Information

Publications11

  1. doi request reprint The 2007 WHO classification of tumors of the central nervous system - what has changed?
    Audrey Rousseau
    Neuropathology Department, Pitie Salpetriere Hospital, Paris, France
    Curr Opin Neurol 21:720-7. 2008
    ....
  2. doi request reprint Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade
    Audrey Rousseau
    UPMC INSERM U711 Neuro Oncologie expérimentale, Paris, France
    J Neurooncol 97:353-64. 2010
    ..Detecting genomic alterations associated with aggressive biological behavior may help stratify patients in high- and low-risk disease...
  3. doi request reprint Genomic changes in progression of low-grade gliomas
    Ahmed Idbaih
    INSERM Unité 711, Paris, France
    J Neurooncol 90:133-40. 2008
    ..21%). Interestingly, putative novel candidate genes associated with glioma progression were identified, in particular DOCK8, PTPRD, CER1, TPHO, DHFR, MSH3, ETS1, ACACA, and CSE1L...
  4. pmc Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas
    Ahmed Idbaih
    Institut National de la Sante et de la Recherche Medicale, U711, Universite Pierre et Marie Curie, Hopital Pitie Salpetriere, Paris, France
    Neuro Oncol 10:540-7. 2008
    ....
  5. doi request reprint Complete response after one cycle of temozolomide in an elderly patient with glioblastoma and poor performance status
    François Ducray
    INSERM, Unité U711, Universite Pierre et Marie Curie Paris VI, Paris, France
    J Neurooncol 88:185-8. 2008
    ..This unusual case report suggests that TMZ warrants further investigation in elderly patients with poor performance status...
  6. doi request reprint A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry
    Soufiane El Hallani
    UMR975, Hopital de la Salpetriere, Universite Pierre et Marie Curie, Paris, France
    Brain 133:973-82. 2010
    ..We describe here a new mechanism of alternative glioblastoma vascularization and open a new perspective for the antivascular treatment strategy...
  7. doi request reprint Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma
    Mathieu Rodero
    Laboratoire d Immunologie Cellulaire, L Institut National de Santé et de Recherche Médicale U543, Paris, France
    J Clin Oncol 26:5957-64. 2008
    ..We hypothesized that genetic polymorphisms in chemokines and their receptors, which together control microglial cell mobilization, may influence survival...
  8. doi request reprint Intracranial solitary fibrous tumor: imaging findings
    Frédéric Clarençon
    Department of Neuroradiology, Pitie Salpetriere Hospital, APHP, 75013 Paris, France
    Eur J Radiol 80:387-94. 2011
    ..To study the neuroimaging features of intracranial solitary fibrous tumors (ISFTs)...
  9. doi request reprint Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors
    Ahmed Idbaih
    INSERM, Unité 711, Paris, Universite Pierre et Marie Curie PARIS6, Laboratoire Biologie des Interactions Neurone Glie, Groupe Hospitalier Pitie Salpetriere, Paris, France
    Brain Res 1198:16-20. 2008
    ..Finally, MDM2 SNP309, alone or in combination with TP53 R72P, was not associated with oligodendroglial tumors...
  10. doi request reprint PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors
    Franck Bielle
    APHP, Hopital Robert Debre, Service de Pathologie, Paris, France
    Am J Surg Pathol 36:1141-9. 2012
    ..Finally, we showed that PHOX2B immunohistochemical analysis improves the diagnosis of undifferentiated neuroblastoma with high specificity and sensitivity...
  11. ncbi request reprint Survivin expression in ganglioglioma
    Audrey Rousseau
    Raymond Escourolle Neuropathology Department, Pitie Salpetriere Hospital, Paris, France
    J Neurooncol 77:153-9. 2006
    ..Survivin expression may carry a negative prognostic value in gangliogliomas...